A Tale of Resilience: Jaguar Health Inc Amid Stock Market Turbulence

Jaguar Health Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $4.37 on 02/10/23, and the lowest price during that time was $0.09, recorded on 01/16/24.

52-week price history of JAGX Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Jaguar Health Inc’s current trading price is -98.13% away from its 52-week high, while its distance from the 52-week low is -4.44%. The stock’s price range during this period has fluctuated between $0.09 and $4.37. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 8.27 million for the day, which was evidently lower than the average daily volume of 9.88 million over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Financial Performance and Market Capitalization

Jaguar Health Inc (JAGX) has experienced a quarterly decline of -71.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.15M and boasts a workforce of 60 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2356, with a change in price of -0.1935. Similarly, Jaguar Health Inc recorded 8,525,366 in trading volume during the last 100 days, posting a change of -68.62%.

JAGX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for JAGX stands at 26.13. Similarly, the long-term debt-to-equity ratio is also 23.17.

JAGX Stock Stochastic Average

The raw stochastic average for Jaguar Health Inc over the last 50 days is presently at 0.91%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 4.68%. Further, the company’s Stochastic %K and %D values for the last 20 days were 5.44% and 7.09%, respectively.

JAGX Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -45.97%. However, over the past six months, we’ve seen a stronger performance of -86.04%. The price of JAGX leaped by -28.87% over the last 30 days. And in the last five days, it has fallen by -15.50%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts